Reuters logo
FDA lifts hold on Seattle Genetics drug trials
March 6, 2017 / 12:06 PM / 9 months ago

FDA lifts hold on Seattle Genetics drug trials

March 6 (Reuters) - Seattle Genetics Inc said on Monday the U.S. Food and Drug Administration had lifted the clinical hold on several early stage studies testing its experimental cancer drug.

The FDA imposed the clinical hold following the deaths of four people in trials testing the company’s experimental cancer drug, vadastuximab talirine, Seattle Genetics said on Dec. 27. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below